ArticleFrontiers in pharmacology2024

Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children's medical center.

Yewei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.